Wissenschaftliches Programm: Donnerstag, 07. Februar 2019

 

Registration and welcome coffee

Welcome & introduction

Prof. Arnold von Eckardstein, MD, Zurich

Keynote 1

Chairperson: Prof. Jürg H. Beer, MD, Baden

Transendothelial lipoprotein transport

Prof. Arnold von Eckardstein, MD, Zurich

Free Communications

Chairperson: Prof. Jürg H. Beer, MD, Baden

Poster Session/Tour and Lunch

Keynote 2

Chairpersons: Prof. Arnold von Eckardstein, MD, Zurich / Prof. Jürg H. Beer, MD, Baden

Inflammation and Diabetes (incl. CANTOS Study)

Prof. Marc Donath, MD, Basel

AGLA Award Session

Swiss Lipid Research Award 2018 (sponsored by Amgen)

Mechanisms of lipid-induced cell dysfunction in pre-diabetes
Lucie Oberhauser, Genf
 

Awards for Clinical Excellence in Lipidology 2018 (sponsored by Sanofi)

Impact of CD14 polymorphisms on anti-apoA-1 IgG-related CAD risk
Panagiotis Antiochos, MD, Lausanne

Eligibility for PCSK9 Inhibitors According to Guidelines After ACS
Baris Gencer, MD, Geneva
 

Award «Best Free Communication» and «Best Posters» (sponsered by AstraZeneca)

Running Up Award (sponsored by AGLA)

Pause

Aus der Praxis für die Praxis

Chairpersons: PD David Nanchen, MD, Lausanne / Prof. Jürg H. Beer, MD, Baden

Thromboembolie und antithrombotische Therapie

Prof. Jürg H. Beer, MD, Baden

Progrès dans le diagnostic et le traitement des hypertriglycéridémies majeures

Prof. Philippe Moulin, MD, Lyon

Pause

Aus der Praxis für die Praxis (Fortsetzung)

Chairpersons: PD David Nanchen, MD, Lausanne / Prof. Jürg H. Beer, MD, Baden

PCSK9 – Indications et limitations

Prof. François Mach, MD, Genève

2018 ESC/ESH Hypertonie Leitlinie: Bedeutung für die Praxis

PD Isabella Sudano, MD, Zürich

Schlussworte

Prof. Jürg H. Beer, MD, Baden / PD David Nanchen, MD, Lausanne